Atlas Trials

Unilateral HER2 Positive Breast Cancer

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Unilateral HER2 Positive Breast Cancer

RecordFirmDate
Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy (NCT01594177)GBG Forschungs GmbH2012-05-01

Track Unilateral HER2 Positive Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.